Entasis Therapeutics Funding: $122M Raised, Series B (2017)

Entasis Therapeutics funding overview

Entasis Therapeutics is based in Waltham, MA. Entasis Therapeutics has raised $122M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2017. The round record for Entasis Therapeutics runs through 2017; nothing later has been disclosed. Investors on record include AstraZeneca Clarus Ventures, Eventide Asset Management, Frazier Healthcare, Novo A/S, Sofinnova Ventures, TPG Biotech. 6 distinct backers are named across the disclosed rounds.

Entasis Therapeutics at a glance

Total raised: $122M
Latest round: Series B
Latest round date: January 2017
Headquarters: Waltham, MA
Notable investors: AstraZeneca Clarus Ventures, Eventide Asset Management, Frazier Healthcare, Novo A/S, Sofinnova Ventures, TPG Biotech

Frequently asked about Entasis Therapeutics funding

How much has Entasis Therapeutics raised?: Entasis Therapeutics has raised $122M in total disclosed funding across the rounds on record.
Who has invested in Entasis Therapeutics?: AstraZeneca Clarus Ventures, Eventide Asset Management, Frazier Healthcare, Novo A/S, Sofinnova Ventures, TPG Biotech are named among the investors backing Entasis Therapeutics.
What was the latest Entasis Therapeutics funding round?: The most recent disclosed round is a Series B, announced in January 2017.
Where is Entasis Therapeutics based?: Entasis Therapeutics is based in Waltham, MA.
When did Entasis Therapeutics last raise?: The last disclosed Entasis Therapeutics round closed in January 2017 at Series B.

Entasis Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Waltham below to benchmark round size and investor mix.

Entasis Therapeutics Funding: $122M Raised, Series B (2017)

Entasis Therapeutics funding overview

Entasis Therapeutics at a glance

Frequently asked about Entasis Therapeutics funding

Companies related to Entasis Therapeutics (18)

Browse related funding lists (4)